LUVITRA
Board
2 directors, since incorporationDirector (not named in the articles)
since 10-05-2021
term without a fixed end
listed in the 2025 annual accounts, filed on 24-09-2026
Director (not named in the articles)
since 10-05-2021
term without a fixed end
listed in the 2025 annual accounts, filed on 24-09-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 12-05-2021
Mandates through the years
2 names, the dashed line is todayDemuynck Thalia Candra Veronica
Director (not named in the articles)
Director (not named in the articles)
Feys Laurens
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- Demuynck Thalia Candra Veronica
- Director (not named in the articles), from 10-05-2021 to date
- Feys Laurens
- Director (not named in the articles), from 10-05-2021 to date
Control
Founders
This company
LUVITRA
Equity €86,236
Profit €28,040 in 2025
Capital
- Contribution
- €5,000
- Shares
- 500
- Contribution per share
- €10
- Equity per share
- €172 in 2025
- Source
- deed of 12-05-2021
Articles of association
deed of 12-05-2021 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 18:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Één of meerdere vereffenaars aanduiden,bevoegdheden omlijnen,vergoeding bepalen, bestuurder(s) in functie als vereffenaar(s) krachtens…”
Shareholders
At incorporation
deed of 12-05-2021 ↗
- Feys Laurens 250 shares (50%) · €2,500
- Demuynck Thalia Candra Veronica 250 shares (50%) · €2,500